Biogen Likes Biosimilars
Biogen Inc (BIIB US) , the partner of Samsung Biologics Co., Ltd (207940 KS) in the Samsung Bioepis JV, reported Q2 2017 results this morning and...
484 Views
JNJ's REMICADE Holds: PFE's Results To Confirm
Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...
518 Views
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...
301 Views
Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate
Celltrion Healthcare (091990 KS)'s bookbuilding is now in progress among overseas investors, and local bookbuilding will begin tomorrow and end on...
277 Views
The Week That Was in NorthAsia@Smartkarma: N. Korea Escalation, Idemitsu Feud and Korea Holdcos
This week Prasenjit K. Basu incites discussion into the policies of the Trump administration centring on recent developments on the Korean...
197 Views